Jamestown Canyon Virus Seroprevalence in Endemic Regions and Implications for Diagnostic Testing

Jamestown Canyon virus, a mosquito-borne virus, can cause asymptomatic infection, febrile illness, or neuroinvasive disease in humans. Previous studies have found Jamestown Canyon virus-specific antibodies in a 4%-54% of people in various U.S. regions. To understand baseline seroprevalence in region...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Clinical infectious diseases Ročník 81; číslo 2; s. 397
Hlavní autori: Sutter, Rebekah A, Calvert, Amanda E, Grimm, Kacie, Biggerstaff, Brad J, Thrasher, Elisa, Mossel, Eric C, Martin, Stacey W, Lehman, Jennifer, Saa, Paula, Townsend, Rebecca, Krysztof, David, Brown, Catherine M, Osborne, Matthew, Hopkins, Brandi, Osborn, Rebecca, Lee, Xia, Schiffman, Elizabeth K, Brault, Aaron C, Basavaraju, Sridhar V, Stramer, Susan L, Staples, J Erin, Gould, Carolyn V
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 16.09.2025
Predmet:
ISSN:1537-6591, 1537-6591
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Jamestown Canyon virus, a mosquito-borne virus, can cause asymptomatic infection, febrile illness, or neuroinvasive disease in humans. Previous studies have found Jamestown Canyon virus-specific antibodies in a 4%-54% of people in various U.S. regions. To understand baseline seroprevalence in regions with the highest number of reported disease cases, we performed a serosurvey among blood donors. We randomly selected blood donation specimens collected during December 2019-April 2020 from residents of counties reporting ≥2 disease cases in 2019 or 1 case in 2019 and ≥1 case during 2010-2018. Specimens were screened for Jamestown Canyon virus-specific neutralizing antibodies and, if positive, tested for immunoglobulin M (IgM) antibodies. We estimated county population seroprevalence by calibrating sample weights to population census data. Fourteen counties in 3 states, Massachusetts, Minnesota, and Wisconsin, met the inclusion criteria. Within each state, average county seroprevalence ranged from 16.8% (95% confidence interval [CI], 9.3-27.0) to 18.8% (95% CI, 14.0-24.4) for Jamestown Canyon virus-neutralizing antibodies and from 7.6% (95% CI, 4.2-12.5) to 13.5% (95% CI, 9.6-18.3) for both neutralizing and IgM antibodies. Estimated Jamestown Canyon virus seroprevalence, including for IgM antibodies, is elevated in endemic areas, complicating the interpretation of serologic testing in diagnosing acute disease in symptomatic individuals. Diagnosing Jamestown Canyon virus disease requires a high degree of clinical suspicion, ruling out other possible causes of illness, and if possible, collecting acute and convalescent samples. New assays to detect acute infection could improve diagnosis and public health surveillance for Jamestown Canyon virus disease.
AbstractList Jamestown Canyon virus, a mosquito-borne virus, can cause asymptomatic infection, febrile illness, or neuroinvasive disease in humans. Previous studies have found Jamestown Canyon virus-specific antibodies in a 4-54% of people in various U.S. regions. To understand baseline seroprevalence in regions with the highest number of reported disease cases, we performed a serosurvey among blood donors.BACKGROUNDJamestown Canyon virus, a mosquito-borne virus, can cause asymptomatic infection, febrile illness, or neuroinvasive disease in humans. Previous studies have found Jamestown Canyon virus-specific antibodies in a 4-54% of people in various U.S. regions. To understand baseline seroprevalence in regions with the highest number of reported disease cases, we performed a serosurvey among blood donors.We randomly selected blood donation specimens collected during December 2019-April 2020 from residents of counties reporting ≥2 disease cases in 2019 or one case in 2019 and ≥1 case during 2010-2018. Specimens were screened for Jamestown Canyon virus-specific neutralizing antibodies and, if positive, tested for IgM antibodies. We estimated county population seroprevalence by calibrating sample weights to population census data.METHODSWe randomly selected blood donation specimens collected during December 2019-April 2020 from residents of counties reporting ≥2 disease cases in 2019 or one case in 2019 and ≥1 case during 2010-2018. Specimens were screened for Jamestown Canyon virus-specific neutralizing antibodies and, if positive, tested for IgM antibodies. We estimated county population seroprevalence by calibrating sample weights to population census data.Fourteen counties in three states, Massachusetts, Minnesota, and Wisconsin, met the inclusion criteria. Within each state, average county seroprevalence ranged from 16.8% (95% CI: 9.3%-27.0%) to 18.8% (95% CI: 14.0%-24.4%) for Jamestown Canyon virus neutralizing antibodies and from 7.6% (95% CI: 4.2%-12.5%) to 13.5% (95% CI: 9.6%-18.3%) for both neutralizing and IgM antibodies.RESULTSFourteen counties in three states, Massachusetts, Minnesota, and Wisconsin, met the inclusion criteria. Within each state, average county seroprevalence ranged from 16.8% (95% CI: 9.3%-27.0%) to 18.8% (95% CI: 14.0%-24.4%) for Jamestown Canyon virus neutralizing antibodies and from 7.6% (95% CI: 4.2%-12.5%) to 13.5% (95% CI: 9.6%-18.3%) for both neutralizing and IgM antibodies.Estimated Jamestown Canyon virus seroprevalence, including for IgM antibodies, is elevated in endemic areas, complicating the interpretation of serologic testing in diagnosing acute disease in symptomatic individuals. Diagnosing Jamestown Canyon virus disease requires a high degree of clinical suspicion, ruling out other possible causes of illness, and if possible, collecting acute and convalescent samples. New assays to detect acute infection could improve diagnosis and public health surveillance for Jamestown Canyon virus disease.CONCLUSIONSEstimated Jamestown Canyon virus seroprevalence, including for IgM antibodies, is elevated in endemic areas, complicating the interpretation of serologic testing in diagnosing acute disease in symptomatic individuals. Diagnosing Jamestown Canyon virus disease requires a high degree of clinical suspicion, ruling out other possible causes of illness, and if possible, collecting acute and convalescent samples. New assays to detect acute infection could improve diagnosis and public health surveillance for Jamestown Canyon virus disease.
Jamestown Canyon virus, a mosquito-borne virus, can cause asymptomatic infection, febrile illness, or neuroinvasive disease in humans. Previous studies have found Jamestown Canyon virus-specific antibodies in a 4%-54% of people in various U.S. regions. To understand baseline seroprevalence in regions with the highest number of reported disease cases, we performed a serosurvey among blood donors. We randomly selected blood donation specimens collected during December 2019-April 2020 from residents of counties reporting ≥2 disease cases in 2019 or 1 case in 2019 and ≥1 case during 2010-2018. Specimens were screened for Jamestown Canyon virus-specific neutralizing antibodies and, if positive, tested for immunoglobulin M (IgM) antibodies. We estimated county population seroprevalence by calibrating sample weights to population census data. Fourteen counties in 3 states, Massachusetts, Minnesota, and Wisconsin, met the inclusion criteria. Within each state, average county seroprevalence ranged from 16.8% (95% confidence interval [CI], 9.3-27.0) to 18.8% (95% CI, 14.0-24.4) for Jamestown Canyon virus-neutralizing antibodies and from 7.6% (95% CI, 4.2-12.5) to 13.5% (95% CI, 9.6-18.3) for both neutralizing and IgM antibodies. Estimated Jamestown Canyon virus seroprevalence, including for IgM antibodies, is elevated in endemic areas, complicating the interpretation of serologic testing in diagnosing acute disease in symptomatic individuals. Diagnosing Jamestown Canyon virus disease requires a high degree of clinical suspicion, ruling out other possible causes of illness, and if possible, collecting acute and convalescent samples. New assays to detect acute infection could improve diagnosis and public health surveillance for Jamestown Canyon virus disease.
Author Saa, Paula
Lehman, Jennifer
Biggerstaff, Brad J
Stramer, Susan L
Krysztof, David
Osborn, Rebecca
Martin, Stacey W
Grimm, Kacie
Brown, Catherine M
Basavaraju, Sridhar V
Gould, Carolyn V
Thrasher, Elisa
Lee, Xia
Calvert, Amanda E
Osborne, Matthew
Sutter, Rebekah A
Brault, Aaron C
Schiffman, Elizabeth K
Townsend, Rebecca
Hopkins, Brandi
Mossel, Eric C
Staples, J Erin
Author_xml – sequence: 1
  givenname: Rebekah A
  orcidid: 0009-0006-6695-7421
  surname: Sutter
  fullname: Sutter, Rebekah A
  organization: Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
– sequence: 2
  givenname: Amanda E
  orcidid: 0000-0002-8237-2654
  surname: Calvert
  fullname: Calvert, Amanda E
  organization: Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
– sequence: 3
  givenname: Kacie
  surname: Grimm
  fullname: Grimm, Kacie
  organization: American Red Cross Scientific Affairs, Gaithersburg, Maryland, USA
– sequence: 4
  givenname: Brad J
  orcidid: 0000-0002-3105-3530
  surname: Biggerstaff
  fullname: Biggerstaff, Brad J
  organization: Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
– sequence: 5
  givenname: Elisa
  surname: Thrasher
  fullname: Thrasher, Elisa
  organization: Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
– sequence: 6
  givenname: Eric C
  orcidid: 0000-0002-2315-4577
  surname: Mossel
  fullname: Mossel, Eric C
  organization: Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
– sequence: 7
  givenname: Stacey W
  orcidid: 0000-0003-1767-6042
  surname: Martin
  fullname: Martin, Stacey W
  organization: Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
– sequence: 8
  givenname: Jennifer
  orcidid: 0000-0001-7114-208X
  surname: Lehman
  fullname: Lehman, Jennifer
  organization: Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
– sequence: 9
  givenname: Paula
  orcidid: 0000-0001-6077-4532
  surname: Saa
  fullname: Saa, Paula
  organization: American Red Cross Scientific Affairs, Gaithersburg, Maryland, USA
– sequence: 10
  givenname: Rebecca
  surname: Townsend
  fullname: Townsend, Rebecca
  organization: American Red Cross Scientific Affairs, Gaithersburg, Maryland, USA
– sequence: 11
  givenname: David
  surname: Krysztof
  fullname: Krysztof, David
  organization: American Red Cross Scientific Affairs, Gaithersburg, Maryland, USA
– sequence: 12
  givenname: Catherine M
  surname: Brown
  fullname: Brown, Catherine M
  organization: Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA
– sequence: 13
  givenname: Matthew
  surname: Osborne
  fullname: Osborne, Matthew
  organization: Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA
– sequence: 14
  givenname: Brandi
  surname: Hopkins
  fullname: Hopkins, Brandi
  organization: Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA
– sequence: 15
  givenname: Rebecca
  orcidid: 0009-0004-1079-3558
  surname: Osborn
  fullname: Osborn, Rebecca
  organization: Division of Public Health, Wisconsin Department of Health Services, Madison, Wisconsin, USA
– sequence: 16
  givenname: Xia
  orcidid: 0000-0001-9248-3940
  surname: Lee
  fullname: Lee, Xia
  organization: Division of Public Health, Wisconsin Department of Health Services, Madison, Wisconsin, USA
– sequence: 17
  givenname: Elizabeth K
  orcidid: 0000-0001-5153-7471
  surname: Schiffman
  fullname: Schiffman, Elizabeth K
  organization: Infectious Disease Epidemiology, Prevention, and Control Division, Minnesota Department of Health, St. Paul, Minnesota, USA
– sequence: 18
  givenname: Aaron C
  surname: Brault
  fullname: Brault, Aaron C
  organization: Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
– sequence: 19
  givenname: Sridhar V
  surname: Basavaraju
  fullname: Basavaraju, Sridhar V
  organization: Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
– sequence: 20
  givenname: Susan L
  surname: Stramer
  fullname: Stramer, Susan L
  organization: American Red Cross Scientific Affairs, Gaithersburg, Maryland, USA
– sequence: 21
  givenname: J Erin
  surname: Staples
  fullname: Staples, J Erin
  organization: Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
– sequence: 22
  givenname: Carolyn V
  orcidid: 0000-0002-8216-0803
  surname: Gould
  fullname: Gould, Carolyn V
  organization: Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40139920$$D View this record in MEDLINE/PubMed
BookMark eNpNkE1LxDAQhoOsuB968i45eqlmknabHGVddWVB0MVrTZPpEmmT2myV_fcWXcHD8A4vD8_ATMnIB4-EnAO7AqbEtXF2GF2BgCMygUzkyTxTMPq3j8k0xnfGACTLTsg4ZSCU4mxC3h51g3EXvjxdaL8Pnr66ro_0BbvQdvipa_QGqfN06S02ztBn3LrgI9Xe0lXT1s7o3U9RhY7eOr31Ie4GbjNond-ekuNK1xHPDjkjm7vlZvGQrJ_uV4ubdWIE57vEMCnnSikBGVoJuQZkvERhc5mmspRijoC5NDbPSgResdSKDDDNudA543xGLn-1bRc--uF00bhosK61x9DHQoDkA6y4GNCLA9qXDdqi7Vyju33x9xT-DQZqZY8
CitedBy_id crossref_primary_10_1155_crdi_4453384
ContentType Journal Article
Copyright Published by Oxford University Press on behalf of Infectious Diseases Society of America 2025.
Copyright_xml – notice: Published by Oxford University Press on behalf of Infectious Diseases Society of America 2025.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/cid/ciaf131
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1537-6591
ExternalDocumentID 40139920
Genre Journal Article
GrantInformation_xml – fundername: CDC
– fundername: Oak Ridge Institute for Science and Education
– fundername: U.S. Department of Energy
GroupedDBID ---
..I
.2P
.I3
.ZR
08P
0R~
29B
36B
4.4
48X
5GY
5RE
5WD
6J9
70D
AABZA
AACGO
AACZT
AAJKP
AAMVS
AANCE
AAOGV
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAVAP
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPLY
ABPQP
ABPTD
ABQLI
ABQNK
ABTLG
ABVGC
ABWST
ABXVV
ABZBJ
ACGFO
ACGFS
ACPRK
ACUFI
ACUTO
ACYHN
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFRAH
AFXAL
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHGBF
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJBYB
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
AQKUS
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CDBKE
CGR
CS3
CUY
CVF
CZ4
DAKXR
DILTD
DU5
D~K
E3Z
EBS
ECM
EE~
EIF
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
H13
H5~
HAR
HW0
HZ~
IOX
J21
JLS
JSG
JXSIZ
KAQDR
KOP
KSI
KSN
L7B
MHKGH
MJL
N9A
NGC
NOMLY
NOYVH
NPM
O9-
OAUYM
OAWHX
OCZFY
ODMLO
ODZKP
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
RD5
ROX
ROZ
RUSNO
RW1
RXO
SJN
TCURE
TEORI
TJX
TMA
TR2
X7H
YAYTL
YKOAZ
YXANX
~91
~S-
7X8
AFYAG
ID FETCH-LOGICAL-c322t-c0886999315ed817a1e02be3d78448b836e1e78cd75be12f04d351e4723a7022
IEDL.DBID 7X8
ISICitedReferencesCount 1
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001471541900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1537-6591
IngestDate Fri Oct 03 00:40:56 EDT 2025
Sun Sep 21 01:50:46 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords seroprevalence
serosurvey
diagnostic testing
Jamestown Canyon virus
blood donor
Language English
License Published by Oxford University Press on behalf of Infectious Diseases Society of America 2025.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c322t-c0886999315ed817a1e02be3d78448b836e1e78cd75be12f04d351e4723a7022
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-1767-6042
0000-0002-8237-2654
0000-0001-9248-3940
0000-0001-6077-4532
0009-0004-1079-3558
0000-0002-2315-4577
0000-0002-8216-0803
0000-0001-5153-7471
0000-0002-3105-3530
0009-0006-6695-7421
0000-0001-7114-208X
PMID 40139920
PQID 3182472923
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3182472923
pubmed_primary_40139920
PublicationCentury 2000
PublicationDate 2025-Sep-16
PublicationDateYYYYMMDD 2025-09-16
PublicationDate_xml – month: 09
  year: 2025
  text: 2025-Sep-16
  day: 16
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Clinical infectious diseases
PublicationTitleAlternate Clin Infect Dis
PublicationYear 2025
SSID ssj0011805
Score 2.494974
Snippet Jamestown Canyon virus, a mosquito-borne virus, can cause asymptomatic infection, febrile illness, or neuroinvasive disease in humans. Previous studies have...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 397
SubjectTerms Adolescent
Adult
Aged
Antibodies, Neutralizing - blood
Antibodies, Viral - blood
Blood Donors
Encephalitis Virus, California - immunology
Encephalitis, California - diagnosis
Encephalitis, California - epidemiology
Endemic Diseases
Female
Humans
Immunoglobulin M - blood
Male
Middle Aged
Seroepidemiologic Studies
Young Adult
Title Jamestown Canyon Virus Seroprevalence in Endemic Regions and Implications for Diagnostic Testing
URI https://www.ncbi.nlm.nih.gov/pubmed/40139920
https://www.proquest.com/docview/3182472923
Volume 81
WOSCitedRecordID wos001471541900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaAIsTCu1BeMhJr1NhO4mRCqLSCoVWFKtQtxC_UxSlNy-_nnLgqAwMSSzYr8eXu_J3vsz-E7iOqYx5lOgilkzCToSMBxCIQSWaUiZRkJqzFJvholE6n2dhvuFWeVrnOiXWiVqV0e-Rd8D0aARKk7GH-GTjVKNdd9RIa26jFAMo4r-bTTReBpDWFEYKaB0mcEX8-D4r4roRfDZM3xKvL_Yot6zVmcPjfrztCBx5d4sfGHY7RlrYnaG_o--en6L0mxS6h8sY9yAKlxW-zxarCkDGcGgp4nQt0PLO4b2vaPH7VjrBc4cIq_PKDfY4B7OKnhqcHL8MTd1uH_ThDk0F_0nsOvMZCICGUl4GELJMASGQk1iolvCA6pEIzxVMo3ETKEk00T6XisdCEmjBSLCYa5soKDut_G-3Y0uoLhKUhVEhqGDEChrpKjMZKQTIFlBAp0UF3a9Pl4MKuL1FYXa6qfGO8Djpv7J_Pm7s2clf-ZRkNL_8w-grtU6fO6wQekmvUMhDA-gbtyq_lrFrc1r4Bz9F4-A0h_8R0
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Jamestown+Canyon+Virus+Seroprevalence+in+Endemic+Regions+and+Implications+for+Diagnostic+Testing&rft.jtitle=Clinical+infectious+diseases&rft.au=Sutter%2C+Rebekah+A&rft.au=Calvert%2C+Amanda+E&rft.au=Grimm%2C+Kacie&rft.au=Biggerstaff%2C+Brad+J&rft.date=2025-09-16&rft.issn=1537-6591&rft.eissn=1537-6591&rft_id=info:doi/10.1093%2Fcid%2Fciaf131&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1537-6591&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1537-6591&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1537-6591&client=summon